20.52MMarket Cap1.03P/E (TTM)
3.1700High3.0200Low9.15KVolume3.0200Open3.0500Pre Close28.40KTurnover0.19%Turnover RatioLossP/E (Static)6.66MShares6.909952wk High0.34P/B15.22MFloat Cap3.020052wk Low--Dividend TTM4.94MShs Float12210.9816Historical High--Div YieldTTM4.92%Amplitude3.0200Historical Low3.1020Avg Price1Lot Size
MEI Pharma Stock Forum
NEWS
MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients
MEI Pharma, Inc. reports positive results from the ongoing Phase 1b study of ME-344 in combination with bevacizumab for relapsed metastatic colorectal cancer. 25% of patients had no disease progression at Week 16, exceeding the threshold to add more patients. The combination was well-tolerated, leading to the...
Uptrending
Suspended
what's next?
AM watch ☀️ ☕️
$Gossamer Bio(GOSS.US)$$Starry Group(STRY.US)$$Helbiz(HLBZ.US)$$MEI Pharma(MEIP.US)$$Digital Brands Group(DBGI.US)$$Cosmos Health(COSM.US)$$COMSovereign(COMS.US)$$Mirati Therapeutics(MRTX.US)$$United Parcel Service(UPS.US)$$Sumo Logic(SUMO.US)$
oversold play
12/6 Watchlist
wherr is thr link for earnings
Massive Insider Buying In This Penny Stock!
🌕
Tomorrow to the 🚀🌕
https://www.etfdailynews.com/2022/05/02/mei-pharma-inc-nasdaqmeip-sees-significant-increase-in-short-interest/
Finally
No comment yet